Literature DB >> 6434575

Hormonal profile of Leydig cell tumors with gynecomastia.

J P Bercovici, K Nahoul, D Tater, J F Charles, R Scholler.   

Abstract

The hormonal profile of estrogen-secreting Leydig cell tumors was studied in four patients. Plasma testosterone (T) and estradiol (E2) levels varied from day-to-day whereas the T/E2 ratios were decreased (22:85, normal 170 to 440). hCG administration induced a higher estrogen response in the patients than in normal men. The finding in the spermatic venous blood of the tumor-bearing testis of a particular biochemical profile, including a low T/E2 ratio (12:27), associated with high progesterone/17-hydroxyprogesterone ratios (0.13:0.26) and high 17-hydroxyprogesterone-androstenedione ratios (26:44), allowed localization of a small testicular tumor when no testicular abnormality was found clinically. Also, the E2 level was moderately elevated in the spermatic vein of one patient compared with normal men. Spermatic venous blood also was obtained after hCG administration in two patients. Increased estrogen and reduced T responses were found in the tumoral testis in comparison with the contralateral testis. In conclusion, the hormone content of spermatic venous effluent from testes containing an interstitial cell tumor is abnormal in several respects and such abnormalities allow detection of the tumor when it is not recognizable clinically.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434575     DOI: 10.1210/jcem-59-4-625

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  Gynaecomastia--pathophysiology, diagnosis and treatment.

Authors:  Harmeet S Narula; Harold E Carlson
Journal:  Nat Rev Endocrinol       Date:  2014-08-12       Impact factor: 43.330

2.  Occult Leydig cell testicular tumour presenting with gynaecomastia.

Authors:  J J O'Donovan; T R Terry; G Williams
Journal:  J R Soc Med       Date:  1989-01       Impact factor: 5.344

3.  Leydig cell tumor estrogen secretion: suppression by a gonadotropin releasing hormone agonist.

Authors:  P Valensi; C Coussieu; E Killian; N Tran-Quang; J R Attali; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1991 Jul-Aug       Impact factor: 4.256

4.  Feminizing Leydig cell tumor: endocrine and incubation studies.

Authors:  P Valensi; C Coussieu; A Pauwels; J R Attali; J L Kemeny; J Amouroux; J Sebaoun
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

5.  Anti-Cancer Effect of Cordycepin on FGF9-Induced Testicular Tumorigenesis.

Authors:  Ming-Min Chang; Siou-Ying Hong; Shang-Hsun Yang; Chia-Ching Wu; Chia-Yih Wang; Bu-Miin Huang
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

6.  Spontaneous adenolipoma of the mammary gland in the male F344 rat.

Authors:  Tetsuya Ide; Young-Man Cho; Yuji Oishi; Kumiko Ogawa
Journal:  J Toxicol Pathol       Date:  2021-03-28       Impact factor: 1.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.